Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Investment analysts at Lifesci Capital ... up from their previous forecast of ($2.95). The consensus estimate for Corbus ...
Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for shares of Corbus Pharmaceuticals in a research note issued to investors on Wednesday, March ...
Hosted on MSN27d
William Blair Initiates Coverage of Corbus Pharmaceuticals Holdings (CRBP) with Outperform RecommendationAnalyst Price Forecast Suggests 690.09% Upside As of February 19, 2025, the average one-year price target for Corbus Pharmaceuticals Holdings is $57.91/share. The forecasts range from a low of $35 ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Prelude Therapeutics (PRLD – Research Report) ...
The stock's fall snapped a two-day winning streak.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback